Heterocyclic chemistry is the interesting area for the effective approach and for the invention of biologically active 1,3,4-oxadiazole cores. 1,3,4-Oxadiazole is a five membered heterocyclic ring which plays key role in the development of new medicinal species for the treatment of numerous diseases. Hence, nowadays researchers have developed the innovative methods for the synthesis of 1,3,4-oxadiazole derivatives and their medicinal applications. Therefore, results of recent developments in the synthesis and biological applications of 1,3,4-oxadiazole candidates over the past 15 years (2005)(2006)(2007)(2008)(2009)(2010)(2011)(2012)(2013)(2014)(2015)(2016)(2017)(2018)(2019) are reviewed in the present article. The information in the present article may be useful to many researchers which lead to exploration of new therapeutic species for the society.
Introduction
Development of new biological compounds based on the molecular recognition is significant goal in the medicinal chemistry and attracted considerable interest. Nowadays, scientists focus on the nitrogen-containing heterocyclic species because of their wide spectrum of pharmacological importance. Compound structure is the main dynamic source to act as a novel biologically active species. Oxadiazole is an aromatic heterocyclic nucleus possessing oxygen (one) and nitrogen (two) atoms in a five-membered heterocyclic ring (molecular formula: C 2 H 2 N 2 O). 1,3,4-Oxdiazole exists in four different isomeric forms namely, 1,2,3-oxadiazole, 1,2,4-oxadiazole, 1,2,5-oxadiazole and 1,3,4-oxadiazole. Among these, 1,3,4-oxadiazole is an important heterocyclic core and becomes significant structural motif for the discovery of new drugs because of its capability to engage in the hydrogen bonding and metabolic profile. 1,3,4-Oxadiazoles undergo several reactions such as photochemical, thermal, electrophilic and nucleophilic substitution. Synthesis of 1,3,4-oxadiazole containing compounds and investigation of their chemical and biological properties has accelerated in recent years. 1,3,4-Oxadiazole represents an important class of biologically active species which exhibits antibacterial [1] , antibiotic [2] , antiviral [3] , anti inflammatory [4] , pesticidal [5] , antiallergic [6] , analgesic [7, 8] , ocular hypotensive [9] , antimalarial [10] , anticancer [11, 12] , anticonvulsant [13, 14] , antitumor [15] [16] [17] , herbicidal [18] , angiogenesis inhibitor [19] , antiedema [20] , anti obesity [21] , antioxidant [22] , anti-infective [23] , anti HIV [24] , antiparasitic [25] , antihyperglycemic [26] , anxiolytic [27] ,antidepressant [28] , antiproliferative [29] , antiplatelet [30] and gastric antisecretory activities [31] . Most of the drugs which are available in the market contains 1,3,4-oxadiazole unit. For examples the compounds containing the 1,3,4-oxadiazole unit currently used in clinical medicine are: Raltegravir (a), an antiretroviral drug and Zibotentan (b) an anticancer agent. Structures are shown in Fig. 1 [32] .
For the synthesis of 1,3,4-oxadiazole the conventional method used are condensation of hydrazides with carbon disulfide, potassium hydroxide and ethanol or intermolecular condensation of acid hydrazide with carboxylic acid in presence of cyclising agents such as phosphorous oxy chloride, polyphosohoric acid, acetic anhydride. The above two methods are most common methods. In this article different groups substituted 1,3,4-oxadiazole is formed using different starting materials and variety of reagents. The different possible methods of preparation of 1,3,4-oxadiazole, the chemical reactivity, and the biological applications of 1,3,4-oxadiazoles have been reviewed in this article. The material in this survey includes some historical methods of preparation of 1,3,4-oxadiazole together with a critical discussion about medicinal applications and also suggestions for future developments.
Taking into account of the significance of 1,3,4-oxadiazoles to both medicinal and heterocyclic chemistry, it was decided to review the synthetic approaches and biological applications of 1,3,4-oxadiazoles over the past fifteen (2005 -2019) years.
Synthesis of 1,3,4-Oxadiazole Using Multicomponent Reaction
In the drug discovery process, multicomponent reaction is a very good method in the organic synthesis of heterocycles. MCR offers many advantages over traditional approaches for the synthesis of variety of fused heterocycles, and chromene.
Along with that, solvent free green synthesis and one pot reaction are also feasible within a short time. With one-pot reactions, each synthesis procedure like weighing of reagents, addition, time control and work-up procedure like quenching, extraction, distillation, chromatography, weighing, and analysis can to be done only once, in contrast to multi-step synthesis. Ali Ramazani et al. [33] reported synthesis of novel 1-(5-aryl-1,3,4-oxadiazol-2-yl)-1-(1H-pyrrol-2-yl)methanamines via one-pot reaction of appropriate benzylamine, pyrrole-2-carbaldehyde, (N-isocyanimino)triphenylphosphorane (Scheme 1), and a carboxylic acid and studied their cytotoxic avtivity.
Synthesis of 1,3,4-Oxadiazoles From the Dehydration of Hydrazines

Synthesis of 1,3,4-Oxadiazoles From Cyclisation With Carbon Disulphide
A new series of 5-(2-hydroxyphenyl)-3-substituted-2,3-dihydro-1,3,4-oxadiazole-2-thiones was prepared by Aboraia et al. [34] For 60-cell panel assay, authors selected 3i, 3j, 3k, 3o , 3p, 3q, and 3r compounds because these compounds hinder the growth of cell lines to 32% or less. The active organic compounds exhibit the broad spectrum antitumor activity against leukemia, non-small cell lung cancer, colon cancer, CNS cancer, melanoma, ovarian, renal, prostate and breast cancer. Authors concluded that, 3j and 3 k show promising anticancer activity with less toxicity. The synthesis of these compounds is easy which made them potent lead species for cancer chemotherapy.
18 novel 1,3,4-oxadiazole derivatives (containing triazole nucleus) were prepared from carbon disulfide and 2-(1H-1,2,4-triazol-l-yl)acetohydrazide through several step reactions. Scheme 3 represents the synthetic route for the target compounds. Authors Liang-zhong et al. [35] in 2008 used these compounds as antifungal agents against Gibberella zeae, Phoma asparagi, Alternaria solani, Cercos-pora arachidicola and Physalospora pircola fungal strains. Among the investigated compounds, 4d and 4h compounds exhibit the good fungal inhibition activity. Naganagowda and Petsom [36] in 2011 reported the synthesis of some new 5-(3-chloro-1-benzothiophen-2-yl)-1,3,4-oxadiazole-2-thiol derivatives. Synthesis route is shown in the Scheme 4a and b. The synthesized compounds were screened for antibacterial and antifungal activity. Antibacterial activity was performed on Bacillus subtilis, Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa. The antifungal activity was performed Crysosporium pannical, Candida albicans, Rhizopus oryzae and Aspergillus niger.
Authors concluded that synthesized organic compounds show moderate anti-bacterial activity against Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa and Bacillus subtilis and noteworthy antifungal activity against Crysosporium pannical, Candida albicans, Rhizopus oryzae and Aspergillus niger.
Zhang et al. [37] in 2012 reported the synthesis, biological evaluation and molecular docking studies of novel 2-(1,3,4-oxadiazol-2-ylthio)-1-phenylethanone derivatives (Scheme 5). The docking study revealed that new series of 2-(1,3,4-oxadiazol-2-ylthio)-1-phenylethanone were potential focal adhesion kinase (FAK) inhibitors. In synthesized series compound 6i was most potent which inhibited the growth of MCF-7 and A431 cell lines Compound 6i also exhibited significant FAK inhibitory activity (IC50 = 20 ± 1 nM).
Sun et al. [38] in 2014 synthesized some 1,3,4-oxadiazole derivatives containing 1,2,3-thiadiazole moiety. Authors synthesized the target compounds by multi-step reactions under microwave condition. Scheme 6 represents the synthetic route for the synthesized compounds. The investigated compounds were screened for herbicidal activity against Echinochloa crusgalli and Brassica campestris.
Authors concluded from their studies that all the synthesized compounds showed good inhibition property against Brassica campestris at a concentration of a 100 μg/mL. Among the studied compounds, 6c showed 75.3% inhibition property at 100 μg/mL and 6e showed 71.9% inhibition property at 100 μg/mL. Compound 6c showed moderate inhibition property i.e. 50.6% even at the concentration of 10 μg/mL. From the study authors concluded that all the Scheme 5 Outline for the synthesis of novel 2-(1,3,4-oxadiazol-2-ylthio)-1-phenylethanone derivatives Scheme 6 Outline for the synthesis of 1,3,4-oxadiazole derivatives containing 1,2,3-thiadiazole moiety other organic compounds exhibited moderate inhibition activity against Brassica campestris. But, all compounds exhibited weak inhibition property against the Echinochloa crusgalli except 6i, which showed moderate inhibition property.
Desai et al. [39] in 2015 prepared the thiazole based 1,3,4-oxadiazole derivatives. Synthetic route for the preparation of these compounds is shown Scheme 7. Synthesized compounds were screened for antibacterial and antifungal activity on Gram-positive bacteria (Streptococcus pyogenes and Staphylococcus aureus), Gram-negative bacteria (Pseudomonas aeruginosa and Escherichia coli) and three fungi (Aspergillus clavatus, Candida albicans and Aspergillus niger).
From their study it was concluded that compounds 5i (2-CH 3 -C 6 H 4 ), 5c (2-OCH 3 -C 6 H 4 ) exibited good inhibition activity against S. aureus and E. coli. Compound 5d (3-OCH 3 -C 6 H 4 ) exhibited good inhibition property against P. aeruginosa. Compound 5e (4-OCH 3 -C 6 H 4 ) exhibited the excellent inhibition against S. aureus, P. aeruginosa and E. coli. Compound 5j (3-CH 3 -C 6 H 4 ) also showed good inhibition property against S.aureus and P. aeruginosa. Compound 5 k (4-CH 3 -C 6 H 4 ) exhibited excellent inhibition property against S. pyogenes and S. aureus. The remaining investigated compounds showed moderate antibacterial activity. Antifungal activity was performed at four different concentrations (1000, 500, 200 and 100 μg/mL). Compound 5a having (2-F-C 6 H 4 ) group showed good inhibition activity against A. clavatus, C. albicans and A. niger. On the other hand compound 5b having (4-F-C 6 H 4 ) showed excellent inhibition activity against A. clavatus, A. niger and C. albicans. The remaining compounds showed weak antifungal activity.
Viveka et al. [40] synthesized some novel Mannich bases and S-alkylated analogs of pyrazole integrated 1,3,4-oxadiazoles as per the Scheme 8 and screened for their bioactivity. All synthesized compounds were tested for in vivo anti inflammatory, in vivo analgesic and in vitro antimicrobial activity. They exhibited significant analgesic and anti inflammatory activity.
Synthesis of 1,3,4-Oxadiazoles Through Oxidative Cyclization Using Chloramine-T
In 2006, Gaonkar et al. [26] prepared the novel series of 2-{4-[2-(5-ethylpyridin-2-yl) ethoxy]phenyl}-5-substituted-1,3,4-oxadiazole derivatives from hydrazones through oxidative cyclization by using the chloramine-T as oxidant (Scheme 9). All the synthesized compounds are exposed to pathogenic microbes. Antimicrobial property of synthesized compounds was examined through microdilution and disc diffusion method against Bacillus substilis, Escherichia coli, Pseudomonas fluorescens, Xanthomonas campestrispvs, Xanthomonas oryzae, Aspergillus niger, Aspergillus flavus, Fusarium oxysporum, Trichoderma species, Penicillum species and Fusarium monaliforme strains. Standard drugs used against bacteria are Tetracycline and Streptomycin. Authors used Nystatin as a standard drug against fungi. Among the tested compounds, 8c and 8d exhibited significant inhibition property. Moderate activity was shown by 8b, 8f, 8 k and 8e compounds. Authors also concluded that, the significant inhibition property of 8e and 8d is due to the two chlorine atoms on benzene ring linked to C5 of oxadiazole nucleus. Moderate inhibitory activity of 8b, 8e and 8f is due to the presence of methoxy, nitro and chloro groups on benzene ring. Presence of 4-pyridinyl group at C5 of oxadiazole nucleus is the main reason for the moderate inhibitory activity of 8i.
Synthesis of 1,3,4-Oxadiazoles From Phenols
Synthesis of 2-[(4-alkylthio/alkylsulfonylphenoxy)methyl]-5-substituted-1,3,4-oxadiazoles have been explained by Karabasanagouda et al. [41] in 2007. The reaction sequences used for the synthesis of oxadiazole derivatives was shown in the Scheme 10a and b. The synthesized compounds were screened for antibacterial activity against Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa and Klebsiella pneumonia stains.
Among the synthesized compounds, 5a, 5b, 5d, 4r, 4u, 4w, 4x and 4y exhibited the good inhibition against all the bacteria strains. The presence of SCH 3 and SH groups at oxadiazole ring and OCH 3 , CH 3 , and Cl groups at the fifth position of oxadiazole nucleus is the main reason for the good activity of the studied compounds. Compounds 4a, 4b, 4c, 4d, 4e, 4g, 4i, 4o, 4q, 4s, 4t and 4v showed moderate inhibition against all bacterial strains. The synthesized compounds were also evaluated for antifungal activity against Aspergilus flavus, Aspergilus fumigates, Trichophyton mentagrophytes and Penicillium marneffei. The compounds namely, 4c, 4d, 4h, 4i, 4j, 4k, 4l, 4m, 4n, 4o, 4p, 4q, 4r, 4s, 4t, 4u,4v, 4w, 4x, 4y, 5a, 5b, 5c, and 5d showed good antifungal activity. These compounds contain active SCH 2 CO 2 H, SCH 3 , SH, OCH 3 , Cl and CH 3 groups in the second position of the oxadiazole nucleus. Compounds 4a, 4b, 4e, 4f and 4g showed moderate antifungal activity.
Amer et al. [42] in 2018 designed and synthesized 1,3,4-oxadiazole moiety bearing sugars and α-aminophosphonate derived from 4-nitrophenol and were tested for their anticancer activity by measuring the inhibitory activity against hepatocellular carcinoma cell. The synthetic scheme is presented in Scheme 11. The synthesized compounds showed moderate-to-high activity against hepatocellular carcinoma cells. 
Synthesis of 1,3,4-Oxadiazoles by Cyclisation With Substituted Aromatic Carboxylic Acids in the Presence of Phosphorous Oxychloride
Some new 2-(3-methyl-7-substituted-2-oxoquinoxalinyl)-5-aryl-1,3,4-oxadiazoles was prepared by Wagle et al. [43] and reported in 2007. The compounds were synthesized as shown in the Scheme 12. The resulting compounds were screened for in vivo analgesic and anti-inflammatory activity.
Among the synthesized compounds, 4a, 4g, 6a and 6b showed good anti-inflammatory activity. Presence of methyl group on seventh position of quinoxaline nucleus and methoxy substitution increased the activity. The compounds 4a, 4g, 4o, 4q and 4w showed the potent analgesic activity. The enhanced hydrophobic nature due to methyl and methoxy groups in the oxadiazole nucleus is responsible for the superior inhibitory activity.
Bhat et al. [44] in 2016 reported the synthesis of 1,3,4-oxadiazole derivatives containing the 3-chloro-2-fluorophenyl nuclei. Synthetic route for the synthesis of organic compounds were shown in the Scheme 13. The synthesized title compounds were screened for their anti inflammatory and anticonvulsant activities. Anticonvulsant activity of synthesized compounds was screened by maximal electroshock method.
Compounds 3a, 3b, 3f, 3j and 5d showed the good anticonvulsant activity. The good inhibition property of 3a and 3b is well supported by minimum binding energies. Compounds 3c, 3d, 3e, 3h, 5c and 5e exhibited the moderate inhibition property. The remaining compounds such as 3 g, 3i, 5a and 5b were non-significant with respect to anticonvulsant activity.
Among the studied compounds, 3a, 3b, 3f, 3 g, 3j, 5c and 5d containing 3,4-dichlorophenyl substituent, 6-chloropyridyl, 2,4-dimethoxyphenyl, pyridyl, 3,5-dichlorophenyl, 2,4-dichlorophenyl and 2-chloro-6-trifluoromethylphenyl respectively exhibited good anti inflammatory activity. The good inhibition property of compounds 3j and 3f was well illustrated by lower binding energy values.
Godhani et al. 
Synthesis of 1,3,4-Oxadiazoles From Long-Chain Alkanoic Acids
Synthesis of 1,3,4-Oxadiazoles From Oxidative Cyclization of N-Acylhydrazones Oxidative Cyclization Using [bis (trifluoroacetoxy)iodo]benzene
Kumar et al. [48] Among the studied compounds, 3c, 3d, and 3j showed good anticancer activity. Authors concluded that, organic compound containing 3-pyridyl or 4-pyridyl substitutions were highly potent and selective. They also found that N-methylation of indole ring nitrogen significantly increased the cytotoxic activity.
Synthesis of 1,3,4-Oxadiazoles by Cyclization of Substituted-Benzoic Acid and Hydrazide Using Phosphorousoxychloride
Rai et al. [49] . Compounds 5c and 5d which are 1,3,4-oxadiazole derivatives exhibited significant cytotoxic properties when compared to standard podophyllotoxin.
Synthesis of 1,3,4-Oxadiazoles Involving Suzuki-Miyaura Coupling Using Palladium Catalyst
Ramaprasad et al. [51] in 2010 prepared series of biphenyl-1,3,4-oxadiazole derivatives by Suzuki-Miyaura The compounds 5c, 6c, 7c and 8c showed good inhibition due to the presence of fluoro substituent in bi-phenyl ring. Investigated compounds do not show any antifungal activity. Analgesic activity of tested compounds was performed by using Eddy's hot plate process. Compounds 5a-b, 5d, 6a-b, 6d, 7b, 7d and 8b showed high analgesic activity. The compounds 5c, 6c, 7a, 7c, 8a, 8c and 8d showed moderate analgesic activity. Authors also concluded that compound 7c showed highest antibacterial activity among the investigated compounds because of the fluoro substituent. The compound containing ester functional group in the S-alkylated derivative 6a, 6b and 6d exhibited the significant analgesic activity.
Synthesis of 1,3,4-Oxadiazoles From Diacylhydrazine Acylhydrazone via Microwave Irradiation
Cui et al. [52] in 2012 prepared the novel 2,5-disubstituted-1,3,4-oxadiazole derivatives by microwave irradiation method. General synthetic process for the synthesis of title compounds is shown in the Scheme 21. Authors studied the in vivo fungicidal activity of synthesized and intermediate compounds against C. cucumerinum, B. cinerea and R. solanii. Authors revealed that synthesized compounds and intermediates showed the fungicidal activity against R. solanii and B. cinerea at the concentration of a 500 μg/mL in vivo. Finally, authors concluded that 3c, 3e, 4c and 4e exhibited the significant fungicidal activity. All the investigated compounds were found safe for the plants. Authors concluded that effective concentrations (EC 50 ) values of the investigated compounds were in the range of 14.03-48.63 µg/mL against the Botrytis cinerea, which is near to or less than Carbendazim (having EC 50 value 48.68 µg/mL). This indicated the moderate to high antifungal activity of the synthesized compounds. Among the investigated compounds, 4b, 4f and 4g showed high antifungal activity due to their low effective concentration values (less than 20 µg/mL). On the other hand, EC 50 values against Rhizoctonia cerealis were higher which is in the range of 37.39-80.05 µg/mL when compared with Scheme 21 Outline for the synthesis of novel 2,5-disubstituted-1,3,4-oxadiazole derivatives the Carbendazim. This suggests the low inhibition activity of the synthesized compounds.
Synthesis of 1,3,4-Oxadiazole Derivatives by Grinding Method Using 2-Aminonicotinaldehyde and Ethyl 3-(3-Nitrophenyl)-3-Oxopropanoate
Sakram et al. [54] in 2017 investigated the green synthetic procedure for the preparation of 2-(2-(3-nitrophenyl)-1,8-naphthyridin-3-yl)-5-aryl-1,3,4-oxadiazole derivatives. They prepared the compounds by grinding method which is non-hazardous, eco-friendly, provides good yield in short reaction time and no special apparatus is required. The synthetic green route was shown in Scheme 23. All the title compounds were exposed for antibacterial activity against Staphylococcus aureus (Gram-positive bacteria) and Escherichia coli (Gram-negative bacteria). Ampicillin was used as the reference drug. Compounds 6c and 6g showed good antibacterial activity against the Staphylococcus aureus and Escherichia coli. Antifungal activity of synthesized compounds was screened on Candida metapsilosis and Aspergillus niger. For this purpose, authors used Griseofulvin as standard drug. Among the synthesized compounds, 6c and 6 g exhibited good antifungal activity.
Synthesis of 1,3,4-Oxadiazoles From Acyl Hydrazides
Tokumaru et al. [55] in 2017 found new approach to prepare 1,3,4-oxadiazoles. They reported new method to deliver the 2,5-disubstituted oxadiazole directly, avoiding 1,2-diacyl hydrazide intermediate by coupling α-bromo nitroalkanes with acyl hydrazides. The synthetic route for the preparation of 2,5-disubstituted oxadiazole is represented in Scheme 24. Bearing 1, 3, 4 
Synthesis of Dihydropyrimidine (DHPM) Derivatives
Synthesis of 1,2,4-Oxadiazole Linked Imidazothiadiazole
Chakrapania et al. [57] described anticancer activities of 1,2,4-oxadiazole linked imidazothiadiazole derivatives against three human cancer cell lines (A375, MCF-7 and ACHN). The synthetic path is shown in Scheme 26. Among the synthesized compounds, three compounds were most potent and showed good anticancer activity. The range of IC 50 for the compounds 11b, 11c and 11j is determined to be from 0.11 to 2.98 µM. Methoxy and trifluoromethyl substituted compounds showed excellent activity.
Scheme 24
Outline for the synthesis of 2,5-disubstituted oxadiazole derivatives
Scheme 25
Outline for the synthesis of new monastrol analogues bearing 1,3,4-oxadiazole moiety
Synthesis of 1,3,4-Oxadiazoles From Oxidation of Hydrazones Using Hypervalent Iodine
Hypervalent iodine compounds have been established as useful reagents in synthetic organic chemistry due to their ease of handling and wide range of chemical reactivity under mild reaction conditions. Hypervalent iodine oxidation of organic compounds has been successfully used in organic synthesis from many years. This method stands as a feasible alternative for the synthesis of heterocycles [58] . Prakash et al. [59] in 2010 reported an efficient and convenient synthesis of unsymmetrical 2,5-disubstituted 1,3,4-oxadiazoles via oxidation of pyrazolylaldehyde N-acylhydrazones using iodobenzene diacetate (IBD) in dichloromethane (Scheme 27) and evaluated their antibacterial and antifungal activities.
Conclusions
This review has summarized that the intermediate which is involved in all synthesis is cyclization of hydrazides. Mainly the synthetic route for the 1,3,4-oxadiazole is refluxing hydrazides with the aromatic acids in presence of phosphorous oxychloride or with carbon disulfide in presence of alkali. The present review article also presented the biological activities of 1,3,4-oxadiazole derivatives reported in the past 15 years. The main synthetic methods include reaction of hydrazide with aldehydes, cyclodeselanization, cyclodesulfurization of acylhydrazinecarbothioamide, cyclization, oxidative reactions of N-acylhydrazones, cyclodehydration reactions of diacylhydrazines, reaction of hydrazide with triflurinated carbon compound in basic medium and electro-organic cyclization and many more utilizing different types of catalysts and solvents. In the above review we also reported the synthesis of 1,3,4-oxadiazoles from oxidation of hydrazones using hypervalent iodine. The Methods we present in this review may help researchers to plan a new bioactive molecule containing the 1,3,4-oxadiazole unit. Furthermore, we also presented the various biological activities of the 1,3,4-oxadiazole nucleus such as anticancer, antimicrobial, analgesic anti inflammatory, antifungal, fungicidal, herbicidal, anticonvulsant. The derivatives of 1,3,4-oxadiazole which contains electron donating groups such as halogens, methoxy, menthyl, thio group showed excellent inhibition against the microbes when we compared to standards. We feel that certain 1,3,4-oxadiazole will definitely find broad applications and continue to attract much more attention in organic synthesis applications.
